Symphony Life Berhad Balance Sheet Health

Financial Health criteria checks 4/6

Symphony Life Berhad has a total shareholder equity of MYR883.2M and total debt of MYR165.5M, which brings its debt-to-equity ratio to 18.7%. Its total assets and total liabilities are MYR1.1B and MYR266.6M respectively.

Key information

18.7%

Debt to equity ratio

RM165.53m

Debt

Interest coverage ratio	n/a
Cash	RM89.11m
Equity	RM883.22m
Total liabilities	RM266.62m
Total assets	RM1.15b

Recent financial health updates

Recent updates

Symphony Life Berhad's (KLSE:SYMLIFE) 27% Price Boost Is Out Of Tune With Revenues

Mar 31

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Sep 29

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

May 12

Estimating The Intrinsic Value Of Symphony Life Berhad (KLSE:SYMLIFE)

Mar 02

Is Symphony Life Berhad (KLSE:SYMLIFE) An Attractive Dividend Stock?

Feb 02

What Can We Make Of Symphony Life Berhad's (KLSE:SYMLIFE) CEO Compensation?

Jan 13

Symphony Life Berhad (KLSE:SYMLIFE) Has A Somewhat Strained Balance Sheet

Dec 21

Update: Symphony Life Berhad (KLSE:SYMLIFE) Stock Gained 63% In The Last Year

Dec 02

Financial Position Analysis

Short Term Liabilities: SYMLIFE's short term assets (MYR292.3M) exceed its short term liabilities (MYR139.7M).

Long Term Liabilities: SYMLIFE's short term assets (MYR292.3M) exceed its long term liabilities (MYR126.9M).

Debt to Equity History and Analysis

Debt Level: SYMLIFE's net debt to equity ratio (8.7%) is considered satisfactory.

Reducing Debt: SYMLIFE's debt to equity ratio has reduced from 63.2% to 18.7% over the past 5 years.

Debt Coverage: SYMLIFE's debt is not well covered by operating cash flow (8.5%).

Interest Coverage: Insufficient data to determine if SYMLIFE's interest payments on its debt are well covered by EBIT.

Symphony Life Berhad Balance Sheet Health

Financial Health criteria checks 4/6

Key information

Recent financial health updates

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Symphony Life Berhad (KLSE:SYMLIFE) Has A Somewhat Strained Balance Sheet

Recent updates

Symphony Life Berhad Announces Resignation of Wendy Phan Su Ann as Independent and Non Executive Director

Symphony Life Berhad's (KLSE:SYMLIFE) 27% Price Boost Is Out Of Tune With Revenues

Third quarter 2024 earnings released: EPS: RM0.001 (vs RM0 in 3Q 2023)

High number of new directors

Symphony Life Berhad Appoints Tan Yu Wei as Independent and Non Executive Director

Symphony Life Berhad Appoints DATO JASMY BIN ISMAIL as Independent and Non Executive Member of Audit Committee

Second quarter 2024 earnings released: EPS: RM0.002 (vs RM0.009 loss in 2Q 2023)

Symphony Life Berhad Announces Redesignation of Tan Sri Dato' Seri Tan King Tai @ Tan Khoon Hai from Executive Chairman to Non Executive Chairman, Effective 1 October 2023

First quarter 2024 earnings released: RM0.003 loss per share (vs RM0.007 loss in 1Q 2023)

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.06 profit in FY 2022)

Symphony Life Berhad, Annual General Meeting, Sep 06, 2023

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.06 profit in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.001 (vs RM0.097 in 3Q 2022)

Symphony Life Berhad Announces the Resignation of Mr. Teo Chiah Chyi as Non-Independent Director, Effective 01 January 2023

SYMPHONY LIFE BERHAD Appoints TAN SIK EEK as Executive Director, Effective from December 27, 2022

Second quarter 2023 earnings released: RM0.009 loss per share (vs RM0.016 loss in 2Q 2022)

High number of new directors

High number of new directors

Full year 2022 earnings released: EPS: RM0.06 (vs RM0.11 in FY 2021)

Symphony Life Berhad, Annual General Meeting, Sep 07, 2022

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.11 in FY 2021)

Symphony Life Berhad Appoints Wendy Phan Su Ann as Independent and Non Executive Member of Remuneration Committee, Effective 31 March 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

High number of new directors

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Group Chief Financial Officer Ying Ng has left the company

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Independent Non Executive Director Chee Loi has left the company

Full year 2021 earnings released: EPS RM0.11 (vs RM0.12 in FY 2020)

Muar Ban Lee Group Berhad (KLSE:MBL) completed the acquisition of 10.6% stake in Symphony Life Berhad (KLSE:SYMLIFE) from Gajahrimau Capital Sdn. Bhd.

Upcoming dividend of RM0.02 per share

Full year 2021 earnings released: EPS RM0.11 (vs RM0.12 in FY 2020)

Independent & Non-Executive Director has left the company

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Non-Independent Executive Chairman & CEO Mohamed Bin Yahya has left the company

Independent & Non-Executive Director has left the company

Senior Independent Non-Executive Director has left the company

New 90-day high: RM0.64

Estimating The Intrinsic Value Of Symphony Life Berhad (KLSE:SYMLIFE)

Third quarter 2021 earnings released: EPS RM0.032 (vs RM0.065 in 3Q 2020)

Is Symphony Life Berhad (KLSE:SYMLIFE) An Attractive Dividend Stock?

What Can We Make Of Symphony Life Berhad's (KLSE:SYMLIFE) CEO Compensation?

New 90-day low: RM0.53

Symphony Life Berhad (KLSE:SYMLIFE) Has A Somewhat Strained Balance Sheet

Update: Symphony Life Berhad (KLSE:SYMLIFE) Stock Gained 63% In The Last Year

Second quarter 2021 earnings released: EPS RM0.04

New 90-day high - RM0.68

First quarter earnings released

Upcoming Dividend of RM0.02 Per Share

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies